S. Horiguchi

A Phase I Study of<i>In vitro</i>Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer

Shinichiro Motohashi, Aki Ishikawa, Eiichi Ishikawa et al. · Clinical Cancer Research · 2006 · 243 citations

Life Sciences, Immunology, Oncology +17

Combination therapy of <i>in vitro</i>‐expanded natural killer T cells and α‐galactosylceramide‐pulsed antigen‐presenting cells in patients with recurrent head and neck carcinoma

Naoki Kunii, S. Horiguchi, Shinichiro Motohashi et al. · Cancer Science · 2009 · 183 citations · Full text

Medicine, Immunology, Oncology +17

Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy

Kazuki Yamasaki, S. Horiguchi, Motoyoshi Kurosaki et al. · Clinical Immunology · 2010 · 181 citations

Life Sciences, Immunology, Oncology +16

Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer

Tetsuro Uchida, S. Horiguchi, Yuriko Tanaka et al. · Cancer Immunology Immunotherapy · 2007 · 165 citations · Full text

Life Sciences, Immunology, Oncology +10

miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC)

Naoko Kikkawa, Toyoyuki Hanazawa, Lisa Fujimura et al. · British Journal of Cancer · 2010 · 155 citations · Full text

Medicine, Cancer Biology, Oncology +13